Related Experiment Video
Updated: Sep 20, 2025

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
381
Cancer treatment and survivorship statistics, 2025
Nikita Sandeep Wagle1, Leticia Nogueira2, Theresa P Devasia3
1Cancer Surveillance Research, American Cancer Society, Atlanta, Georgia, USA.
CA: a Cancer Journal for Clinicians
|May 30, 2025
Summary
Cancer survivorship in the US is rising, with 18.6 million survivors as of 2025. Significant racial disparities in cancer treatment persist, particularly for lung and rectal cancers, necessitating targeted interventions.
Area of Science:
- Public Health
- Cancer Epidemiology
- Health Disparities
Background:
- The number of cancer survivors in the United States is increasing due to population growth, aging, and improved survival rates from early detection and treatment.
- Cancer prevalence estimation is crucial for public health planning and resource allocation for the growing survivor population.
Purpose of the Study:
- To estimate the current and projected number of cancer survivors in the United States.
- To identify the most prevalent cancer types and describe the demographic characteristics of cancer survivors.
- To analyze racial disparities in cancer treatment and identify areas for targeted intervention.
Main Methods:
- Utilized data from the Surveillance, Epidemiology, and End Results (SEER) cancer registries, National Center for Health Statistics (NCHS), and United States Census Bureau for prevalence estimation.
- Incorporated data from the National Cancer Database to analyze cancer treatment patterns and side effects.
- Examined racial differences in treatment across various cancer stages and types.
Main Results:
- As of January 1, 2025, approximately 18.6 million individuals were living with a history of cancer in the US, projected to reach over 22 million by 2035.
- The most prevalent cancers include prostate, melanoma of the skin, and colorectum in males, and breast, uterine corpus, and thyroid in females.
- Significant racial disparities in treatment were observed, with Black individuals less likely to receive recommended treatments like surgery for lung cancer and proctectomy for rectal cancer compared to White individuals.
Conclusions:
- The growing population of cancer survivors requires continued public health focus and resource allocation.
- Addressing racial disparities in cancer treatment is critical to ensuring equitable care and improving outcomes for all survivors.
- Targeted, multi-level interventions are essential to expand access to high-quality cancer care and survivorship resources, thereby reducing disparities.
Related Concept Videos
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Actuarial Approach
140
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
140
Cancer
49.9K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.9K

